$0.35
-0.005[-1.41%]
At close: May 14
$0.35
0[0.00%]
PreMarket: 7:48PM EDT
Apollomics
(NASDAQ:APLM)Latest News for Apollomics Stock (NASDAQ:APLM)
Apollomics Stock (NASDAQ: APLM)
Categories: All
Wednesday, May 08, 2024
- Apollomics Announces ~$6M Private Placement Financing; Pursuant To The Terms Of The Subscription Agreements, Co Is Selling An Aggregate Of 19,166,666 Class A Ordinary Shares At A Price Of $0.30/ShareBenzinga Newsdesk - 6 days ago
- HC Wainwright & Co. Maintains Buy on Apollomics, Lowers Price Target to $2Benzinga Newsdesk - 6 days ago
Thursday, April 25, 2024
Monday, April 01, 2024
- Apollomics Inc Files For Mixed Shelf Of Up To $200MBenzinga Newsdesk - Apr 1, 2024, 4:34PM
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga Insights - Apr 1, 2024, 4:31PM
- EF Hutton Maintains Buy on Apollomics, Lowers Price Target to $6.5Benzinga Newsdesk - Apr 1, 2024, 8:38AM
- HC Wainwright & Co. Maintains Buy on Apollomics, Lowers Price Target to $5Benzinga Newsdesk - Apr 1, 2024, 6:18AM
Thursday, March 28, 2024
Tuesday, March 26, 2024
Monday, March 04, 2024
Wednesday, February 07, 2024
Tuesday, February 06, 2024
Friday, January 19, 2024
Tuesday, January 09, 2024
Wednesday, January 03, 2024
Thursday, November 30, 2023
Monday, November 27, 2023
- Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day SessionLisa Levin - Nov 27, 2023, 1:41PM
- Why UP Fintech Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving PremarketLisa Levin - Nov 27, 2023, 8:10AM
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - Nov 27, 2023, 8:06AM
Wednesday, November 22, 2023
Monday, November 20, 2023
Thursday, November 16, 2023
- Why Children's Place Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Nov 16, 2023, 1:11PM
- Why Is Cancer Firm Apollomics Stock Trading Higher Today?Vandana Singh - Nov 16, 2023, 10:03AM
- US Stocks Down; Jobless Claims Rise To 231,000Lisa Levin - Nov 16, 2023, 9:43AM
- Market-Moving News for November 16thBenzinga Newsdesk - Nov 16, 2023, 8:45AM
- Apollomics Announces The First Approval Of Vebreltinib For MET Exon 14 Skip Non-Small Cell Lung CancerBenzinga Newsdesk - Nov 16, 2023, 8:34AM
Tuesday, October 31, 2023
Friday, October 27, 2023
- Apollomics shares are trading higher. The company yesterday announced a report on the efficacy response of a patient treated with vebreltinib for GBM with PTPRZ-MET fusion.Benzinga Newsdesk - Oct 27, 2023, 3:46PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Oct 27, 2023, 1:30PM
- Why Barnes Group Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Oct 27, 2023, 1:17PM
- What's Going On With Apollomics Inc Stock?Erica Kollmann - Oct 27, 2023, 10:59AM
- Apollomics Shares Resume TradeBenzinga Newsdesk - Oct 27, 2023, 9:44AM
- Nasdaq Jumps 100 Points; Amazon Posts Upbeat EarningsLisa Levin - Oct 27, 2023, 9:43AM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Oct 27, 2023, 9:05AM
- Why Intel Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving PremarketLisa Levin - Oct 27, 2023, 8:14AM
Thursday, October 26, 2023
Monday, October 23, 2023
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga Insights - Oct 23, 2023, 5:31PM
- Crude Oil Falls Sharply; Apollomics Shares PlungeLisa Levin - Oct 23, 2023, 2:39PM
- Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day SessionLisa Levin - Oct 23, 2023, 1:54PM
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - Oct 23, 2023, 1:31PM
- Nasdaq Turns Higher; Akumin Shares JumpLisa Levin - Oct 23, 2023, 12:06PM
- Apollomics shares are trading lower after the company announced the presentation of vebreltinib efficacy and safety data from the KUNPENG clinical trial at ESMO 2023.Benzinga Newsdesk - Oct 23, 2023, 11:11AM
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - Oct 23, 2023, 9:06AM
- Market-Moving News for October 23rdBenzinga Newsdesk - Oct 23, 2023, 8:56AM
- Apollomics Announces Efficacy Of Vebreltinib In NSCLC Patients With MetEx14 Skipping Mutation Achieving An Overall Response Rate Of 75%Benzinga Newsdesk - Oct 23, 2023, 8:32AM